USPTO serial 98254291
BIOMATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 24, 2026
- Examiner
- STIGLITZ, SUSAN R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOMATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
DEKA Research & Development Corp.
Manchester, NH, US
DEKA Research & Development Corp.
Manchester, NH, US
DEKA Research & Development Corp.
Manchester, NH, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark E. Tetreault
340 COMMERCIAL STREETMANCHESTER, NH 03101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 007 | Biomanufacturing devices for engineering of three-dimensional tissues, organs, and autologous cell samples, namely, 3D bioprinters; Fabrication devices for rejuvenation of tissues, organs, autologous cell samples, namely, tissue rejuvenation devices in the nature of bioprinters | ACTIVE | Nov 7, 2023 |
| 009 | Automated and semi-automated cell culture apparatus for laboratory use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Laboratory equipment and supplies, namely, incubators for cell culturing, cell therapy, tissue manufacturing and organ manufacturing and electronic monitors for monitoring cell culture incubators; Disposable plastic bioreactors for cell culturing; Biochips for the production of three-dimensional living tissues, organs and autologous cell samples for research or scientific purposes; Bioreactors for cell culturing for laboratory use; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers for the purpose of laboratory research; Automated and semi-automated medical equipment for the preparation of autologous and allogeneic biological cell therapies for medical purposes, namely, a fully integrated system composed primarily of computers, electronic sensors, and monitors, plastic tubing, syringes, and pumps, and metal containers, bottles, and heating plates for use in the creation of biological cell therapies, organs, tissues and autologous cell samples for medical purposes; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of medical and scientific research | ACTIVE | Nov 7, 2023 |
| 010 | Automated and semi-automated cell culture apparatus for medical use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Medical devices, namely, electromechanical fluidic instruments, and other similar or related devices, which process complex human body fluids for the purpose of separating human cell culture samples, and separating fluids; Medical instruments for processing of human body fluids in the nature of human cell samples, blood, and plasma, and the isolation and concentration of components thereof for the purpose of treating degenerative diseases, and chronic diseases; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of therapeutic regenerative medical treatment, blood transfusions, and cell transfusions | ACTIVE | Nov 7, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DEKA Research & Development Corp.
- Other trademarks owned by DEKA Research & Development Corp.
- Other trademarks owned by DEKA Research & Development Corp.
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named BIOMATION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 24, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 24, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 3, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 3, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 3, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 3, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 3, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 3, 2026 | SNEA | SU-EXAMINER'S AMENDMENT WRITTEN | — |
| Nov 3, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2025 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 29, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2025 | ALIE | ASSIGNED TO LIE | — |
| Sep 18, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 10, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2025 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 3, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jun 3, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 7, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 12, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 12, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 21, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 1, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 1, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 1, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 1, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 29, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 16, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 2, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 2, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 2, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 2, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 2, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 1, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 1, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 1, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 30, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 30, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 7, 2023 | NWAP | NEW APPLICATION ENTERED | — |